ValiRx PLC (VAL)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.30p

Buy

0.34p

arrow-down-0.045p (-12.33%)

Prices updated at 12 Dec 2025, 16:36 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
ValiRx PLC is a biopharmaceutical company. It is engaged in developing technologies and products in oncology therapeutics and diagnostics focused on the treatment of cancer and associated Biomarkers, specializing in epigenomic and genetic analysis.
FTSE All-Share
arrow-down-0.48%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

-
-
-
-
-
-

Total dividend yield

No data available

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
2025--
2024--
2023--
2022--
2021--
2020--
2019--
2018--
2017--
2016--

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
2025--
2024--
2023--
2022--
2021--
2020--
2019--
2018--
2017--
2016--

Dividend per share

No data available

% of earnings paid to shareholders

No data available

Dividend per share data table

YearDividend per share
2025-
2024-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025-
2024-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
Latest Financial Report as of 12 Dec 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.